适应新现实:新冠疫情早期实践模式调整的评估
该研究通过匿名问卷向妇科肿瘤学会(SGO)成员调查新冠疫情期间妇科肿瘤诊疗模式变化,分析331份回复。99.1%受访社区存在新冠病例,诊疗量下降61.6%,多数取消由医生发起;>94%的医生仍进行妇科肿瘤手术(1级子宫内膜样腺癌除外,36.3%)。主要挑战为手术积压(58.6%)、癌症诊断延迟(43.2%)和恢复延迟患者的正常诊疗(37.8%)。
要点
- 99.1%受访社区存在新冠病例,99.7%报告已采取缓解措施。
- 诊疗量自疫情开始下降61.6%,多数取消由医生发起。
- >94%医生继续妇科肿瘤手术,但1级子宫内膜样腺癌仅36.3%继续手术。
核心结论
- 新冠疫情广泛存在并彻底改变了妇科肿瘤常规诊疗模式,尽管多数诊疗仍在继续,但诊疗量急剧下降表明大量患者未被诊断或正在推迟就医。
研究设计与样本
- 通过电子邮件向妇科肿瘤学会(SGO)成员发放匿名问卷,评估新冠疫情对妇科肿瘤诊疗模式的影响及预期挑战,采用Wilcoxon秩和检验分析新冠感染的危险因素,共分析331名妇科肿瘤医生的回复。
主要发现
- 99.1%的受访社区存在新冠病例,99.7%报告已采取缓解措施;感染率在不同地区间差异显著(p≪0.001),东北部报告病例数最多。
- 自疫情开始以来诊疗量下降61.6%,大多数取消由医生发起;52.8%的回复者认为卵巢癌将是最受新冠影响的癌症。
- >94%的回复者继续开展妇科肿瘤手术,但1级子宫内膜样腺癌例外(36.3%)。
- 疫情消退后的前三大挑战为手术积压(58.6%)、癌症诊断延迟(43.2%)和恢复延迟患者的正常诊疗(37.8%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aim to define national practice patterns to assess current clinical practice, anticipated delays and areas of concern that potentially could lead to deviations from the normal standard of care. METHODS: Anonymous surveys were emailed to members of the Society of Gynecologic Oncology (SGO). The spread of COVID-19 and its impact on gynecologic oncology care in terms of alterations to normal treatment patterns and anticipated challenges were assessed. The Wilcoxon rank sum test was performed to determine risk factors for COVID-19 infection. RESULTS: We analyzed the responses of 331 gynecologic oncology providers. COVID-19 is present in 99.1% of surveyed communities with 99.7% reporting mitigation efforts in effect. The infection rate differs significantly between regions (p≪0.001) with the Northeast reporting the highest number of COVID-19 cases. Practice volume has dropped by 61.6% since the start of the pandemic with most cancellations being provider initiated. A majority of responders (52.8%) believed that ovarian cancer will be the most affected cancer by COVID-19. >94% of responders are proceeding with gynecologic cancer surgeries with exception of grade 1, endometrioid endometrial adenocarcinoma (36.3%). Surgical backlog (58.6%), delayed cancer diagnosis (43.2%) and re-establishing normal care with delayed patient (37.8%) were identified as the top 3 challenges after COVID-19 has abated. CONCLUSIONS: COVID-19 is widespread and has radically altered normal practice patterns. Despite COVID-19 related concerns, most gynecologic oncology care is proceeding. However, the steep decline in clinical volume shows there is a large group of patients who are not being diagnosed or are deferring care.
引用
- Nakayama J, El-Nashar SA, Waggoner S, et al. Adjusting to the new reality: Evaluation of early practice pattern adaptations to the COVID-19 pandemic. Gynecol Oncol. 2020. PMID: 32482336. doi:10.1016/j.ygyno.2020.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。